RIGL · Rigel Pharmaceuticals Inc
$42.58
+1.79 (+4.39%)
At close · Aug 14
Market Cap
$795.39M
Shares
18.68M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-04 | — | |
| 10-Q | 2026-08-04 | 2026-06-30 | |
| 8-K | 2026-07-01 | 2026-06-25 | |
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-06-17 | 2026-06-11 | |
| Investor Event Transcript | 2026-06-03 | 2026-06-30 | |
| 8-K | 2026-05-20 | 2026-05-14 | |
| 8-K | 2026-05-12 | 2026-05-11 | |
| 10-Q | 2026-05-05 | 2026-03-31 | |
| 8-K | 2026-05-05 | — | |
| 8-K | 2026-04-21 | 2026-04-16 | |
| DEF 14A | 2026-04-03 | 2026-05-14 | |
| 8-K | 2026-03-03 | — | |
| 10-K | 2026-03-03 | 2025-12-31 | |
| 8-K | 2026-02-03 | 2026-02-01 | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2025-12-10 | 2025-12-07 | |
| 10-Q | 2025-11-04 | 2025-09-30 | |
| 8-K | 2025-11-04 | — | |
| 10-Q | 2025-08-05 | 2025-06-30 | |
| 8-K | 2025-08-05 | — | |
| 8-K | 2025-05-23 | 2025-05-22 | |
| 10-Q | 2025-05-06 | 2025-03-31 | |
| 8-K | 2025-05-06 | — | |
| DEF 14A | 2025-04-10 | 2025-05-22 | |
| 8-K | 2025-03-27 | — | |
| 8-K | 2025-03-10 | 2025-03-06 | |
| 10-K | 2025-03-04 | 2024-12-31 | |
| 8-K | 2025-03-04 | — | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2024-12-09 | — | |
| 8-K | 2024-11-07 | — | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-09-19 | 2024-09-16 | |
| 8-K | 2024-09-03 | — | |
| 8-K | 2024-08-06 | — | |
| 10-Q | 2024-08-06 | 2024-06-30 | |
| 8-K | 2024-06-27 | — | |
| 8-K | 2024-06-25 | — | |
| 8-K | 2024-05-29 | 2024-05-24 | |
| 10-Q | 2024-05-07 | 2024-03-31 | |
| 8-K | 2024-05-07 | — | |
| 8-K | 2024-04-12 | 2024-04-11 | |
| DEF 14A | 2024-04-10 | 2024-05-22 | |
| 8-K | 2024-03-05 | — | |
| 10-K | 2024-03-05 | 2023-12-31 | |
| 8-K | 2024-02-22 | — | |
| 8-K | 2024-01-08 | — | |
| 8-K | 2023-11-30 | 2023-11-27 | |
| 8-K | 2023-11-07 | — |
Showing 1–50 of 111 filings
Key facts
CIK
1034842
CUSIP
766559702
13F (30d)
155 filings
152 filers
Visit website
Investor relations